New Collaborations
Just as science has advanced tremendously over the last decade, so has our understanding of how we need to collaborate to advance innovation more quickly and effectively.
Our creative approach to external collaboration has resulted in new types of arrangements with government, academia, patient advocacy groups and the biomedical industry.
“Nirogi Kaya has a strong commitment to working in rare diseases. However, the challenge is too great for any one of us to go it alone. Through innovative partnerships with both
academia and industry we hope to progress gene ayurvedic therapy research and bring forth the next generation of potential life-changing ayurvedic therapies for patients living with
serious diseases.”
|